Your browser doesn't support javascript.
loading
Celecoxib, a selective cyclo-oxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer.
Altorki, N K; Keresztes, R S; Port, J L; Libby, D M; Korst, R J; Flieder, D B; Ferrara, C A; Yankelevitz, D F; Subbaramaiah, K; Pasmantier, M W; Dannenberg, A J.
  • Altorki NK; Department of Cardiothoracic Surgery, Strang Cancer Prevention Center and Weill Medical College of Cornell University, New York, NY 10021, USA. nkaltork@med.cornell.edu.
J Clin Oncol ; 21(14): 2645-50, 2003 Jul 15.
Article en En | MEDLINE | ID: mdl-12860939
Search on Google
Banco de datos: MEDLINE Asunto principal: Sulfonamidas / Carboplatino / Inhibidores de la Ciclooxigenasa / Paclitaxel / Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2003 Tipo del documento: Article
Search on Google
Banco de datos: MEDLINE Asunto principal: Sulfonamidas / Carboplatino / Inhibidores de la Ciclooxigenasa / Paclitaxel / Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2003 Tipo del documento: Article